MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 297 filers reported holding MEDIVATION INC in Q3 2014. The put-call ratio across all filers is 1.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $6,727,000 | +29.8% | 111,560 | -1.0% | 0.01% | +50.0% |
| Q1 2016 | $5,181,000 | -36.6% | 112,670 | -33.3% | 0.00% | -42.9% |
| Q4 2015 | $8,171,000 | +12.3% | 169,022 | -1.3% | 0.01% | +16.7% |
| Q3 2015 | $7,275,000 | -90.1% | 171,166 | -73.5% | 0.01% | -90.2% |
| Q2 2015 | $73,831,000 | -4.4% | 646,508 | +8.0% | 0.06% | -3.2% |
| Q1 2015 | $77,240,000 | +960.3% | 598,438 | +718.3% | 0.06% | +950.0% |
| Q4 2014 | $7,285,000 | -13.7% | 73,132 | -14.3% | 0.01% | -14.3% |
| Q3 2014 | $8,438,000 | +14.6% | 85,348 | -10.6% | 0.01% | +16.7% |
| Q2 2014 | $7,362,000 | +19.9% | 95,508 | +0.1% | 0.01% | +20.0% |
| Q1 2014 | $6,141,000 | +32.4% | 95,409 | +31.3% | 0.01% | +25.0% |
| Q4 2013 | $4,637,000 | -67.6% | 72,651 | -69.5% | 0.00% | -71.4% |
| Q3 2013 | $14,295,000 | +301.2% | 238,485 | +229.3% | 0.01% | +250.0% |
| Q2 2013 | $3,563,000 | – | 72,419 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |